Spironolactone Tablet, Film Coated
Product Images NDC 48433-088
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 48433-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Safecor Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Image 02)
This text appears to be a comparison between Spironolactone and Placebo in a study with 822 and 841 participants, respectively. The log-rank test achieved a significant p-value of less than 0.001. The timeline of the study spans from 6 to 48 months. This study outcome suggests that Spironolactone may have a notable effect compared to Placebo.*
Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Image 03)
Spironolactone 50 mg Tablets, Usp Unit Carton Label (Image 04)
Unit Carton (Image 05)
This text appears to be a label from a child-resistant packaging company called Safecor Health Company. The packaging is designed for institutional use, with features like child-resistant sealing to prevent access by children. It includes information such as the company's address in Rockford, IL, a toll-free number for customer service (1-800-447-1006), and a website (SafecorHealth.com).*
Spironolactone 100 mg Tablets, Usp Unit Carton Label (Image 06)
Spironolactone 25 mg Tablets, Usp Unit Carton Label (Image 07)
This is a description of a medication package containing Spironolactone tablets. The National Drug Code (NDC) for this product is 48433-087-20. The package includes 100 tablets with the strength of 10 mg each. The tablets are labeled for prescription-only use. Additionally, a product code and storage information are provided on the package.*
Unit Carton (Image 08)
This text provides information about a thermal container or package distributed by Safecor Health Company. The container is said to be child-resistant and intended for institutional use. It features a safety lock mechanism to keep contents inaccessible to children. The container has a visible window for the user to see the amount and expiration date of the product inside. For more information, contact Safecor Health Company at 1-800-447-1006 or visit safecorhealth.com.*
Unit Carton (Image 09)
This text contains information about a child-resistant safety lid container for institutional use. The container has a child-resistant lid and a window for tracking the content's expiration date. The product is distributed by Safecor Health LLC in Rockford, IL, USA. Additionally, a contact number and website for Safecor Health Company are provided for further information or inquiries.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.